Paper28652111
Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro.
Robinson ES and 5 others. J Invest Dermatol, 2017. Cited by 36 papers, by iCite.
Cite this record
ConductScience Library. Cannabinoid Reduces Inflammatory Cytokines, Tumor Necrosis Factor-α, and Type I Interferons in Dermatomyositis In Vitro. Papers, record 28652111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28652111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cannabinoids | Major topic |
| Cytokines | Major topic |
| Dermatomyositis | Major topic |
| Interferon Type I | Major topic |
| Tumor Necrosis Factor-alpha | Major topic |
| Cohort Studies | |
| Dronabinol | |
| Humans | |
| In Vitro Techniques | |
| Prospective Studies | |
| Sensitivity and Specificity | |
| Severity of Illness Index |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| I01 BX000706 | BLRD VA | United States | I01BX000706 | PubMed and NIH | NIH RePORTER |
| R21 AR066286 | NIAMS NIH HHS | United States | R21AR066286 | PubMed and NIH | NIH RePORTER |
References12
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 24856183 | Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity. | Bioorg Med Chem | 2014 | https://conductscience.org/library/papers/24856183 | PubMed |
| 2 | 19124557 | Ajulemic acid, a synthetic cannabinoid, increases formation of the endogenous proresolving and anti-inflammatory eicosanoid, lipoxin A4. | FASEB J | 2009 | https://conductscience.org/library/papers/19124557 | PubMed |
| 3 | 8508790 | Cannabinoid-receptor expression in human leukocytes. | Eur J Biochem | 1993 | https://conductscience.org/library/papers/8508790 | PubMed |
| 4 | 7689702 | Molecular characterization of a peripheral receptor for cannabinoids. | Nature | 1993 | https://conductscience.org/library/papers/7689702 | PubMed |
| 5 | 18840450 | Ajulemic acid, a synthetic cannabinoid acid, induces an antiinflammatory profile of eicosanoids in human synovial cells. | Life Sci | 2008 | https://conductscience.org/library/papers/18840450 | PubMed |
| 6 | 12566094 | Suppression of human monocyte interleukin-1beta production by ajulemic acid, a nonpsychoactive cannabinoid. | Biochem Pharmacol | 2003 | https://conductscience.org/library/papers/12566094 | PubMed |
| 7 | 11037898 | TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. | Arthritis Rheum | 2000 | https://conductscience.org/library/papers/11037898 | PubMed |
| 8 | 22217359 | Tumor necrosis factor α release in peripheral blood mononuclear cells of cutaneous lupus and dermatomyositis patients. | Arthritis Res Ther | 2012 | https://conductscience.org/library/papers/22217359 | PubMed |
| 9 | 22456539 | Gottron's papules exhibit dermal accumulation of CD44 variant 7 (CD44v7) and its binding partner osteopontin: a unique molecular signature. | J Invest Dermatol | 2012 | https://conductscience.org/library/papers/22456539 | PubMed |
| 10 | 18040689 | Suppression of human macrophage interleukin-6 by a nonpsychoactive cannabinoid acid. | Rheumatol Int | 2008 | https://conductscience.org/library/papers/18040689 | PubMed |
| 11 | 21398612 | Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines. | J Immunol | 2011 | https://conductscience.org/library/papers/21398612 | PubMed |
| 12 | 12921755 | Ajulemic acid, a nonpsychoactive cannabinoid acid, induces apoptosis in human T lymphocytes. | Clin Immunol | 2003 | https://conductscience.org/library/papers/12921755 | PubMed |
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 36 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42076122 | Cannabinoids for Dermatological Applications: Mechanistic Insights, Clinical Evidence, and Emerging Nanotechnology-Enabled Delivery Strategies. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42076122 | PubMed |
| 40285991 | CAR-T cell therapy in rheumatic diseases: a review article. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/40285991 | PubMed |
| 39841219 | Geraniol modulates inflammatory and antioxidant pathways to mitigate intestinal ischemia-reperfusion injury in male rats. | Naunyn Schmiedebergs Arch Pharmacol | 2025 | https://conductscience.org/library/papers/39841219 | PubMed |
| 39403556 | Long-Term Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: Follow-Up Data from a 3-Year Open-Label Extension Study. | JID Innov | 2025 | https://conductscience.org/library/papers/39403556 | PubMed |
| 39343752 | Updates in Dermatomyositis: Newer Treatment Options and Outcome Measures From Dermatologic Perspectives. | Ann Dermatol | 2024 | https://conductscience.org/library/papers/39343752 | PubMed |
| 37378109 | Green Smoke, Red Flag: Cannabis and the Risk of Orbitopathy and Dermopathy in Thyrotoxicosis. | Cureus | 2023 | https://conductscience.org/library/papers/37378109 | PubMed |
| 36816569 | Cannabidiol's neuroprotective properties and potential treatment of traumatic brain injuries. | Front Neurol | 2023 | https://conductscience.org/library/papers/36816569 | PubMed |
| 36552866 | Cannabinoid Compounds as a Pharmacotherapeutic Option for the Treatment of Non-Cancer Skin Diseases. | Cells | 2022 | https://conductscience.org/library/papers/36552866 | PubMed |
| 35490744 | Safety and Efficacy of Lenabasum, a Cannabinoid Receptor Type 2 Agonist, in Patients with Dermatomyositis with Refractory Skin Disease: A Randomized Clinical Trial. | J Invest Dermatol | 2022 | https://conductscience.org/library/papers/35490744 | PubMed |
| 35280763 | COL8A1 Promotes NSCLC Progression Through IFIT1/IFIT3-Mediated EGFR Activation. | Front Oncol | 2022 | https://conductscience.org/library/papers/35280763 | PubMed |
| 35199092 | Cannabinoids for the Treatment of Dermatologic Conditions. | JID Innov | 2022 | https://conductscience.org/library/papers/35199092 | PubMed |
| 34983619 | Cannabinoid type 2 receptor (CB2R) distribution in dermatomyositis skin and peripheral blood mononuclear cells (PBMCs) and in vivo effects of LenabasumTM. | Arthritis Res Ther | 2022 | https://conductscience.org/library/papers/34983619 | PubMed |
| 34938263 | TNFα in MS and Its Animal Models: Implications for Chronic Pain in the Disease. | Front Neurol | 2021 | https://conductscience.org/library/papers/34938263 | PubMed |
| 34531934 | The Effect of Medical Cannabis on Pain Level and Quality of Sleep among Rheumatology Clinic Outpatients. | Pain Res Manag | 2021 | https://conductscience.org/library/papers/34531934 | PubMed |
| 34072930 | Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier. | J Pers Med | 2021 | https://conductscience.org/library/papers/34072930 | PubMed |
| 33842662 | Pruritus in autoimmune connective tissue diseases. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33842662 | PubMed |
| 32637881 | Thymoquinone reduces ischemia and reperfusion-induced intestinal injury in rats, through anti-oxidative and anti-inflammatory effects. | Turk J Surg | 2020 | https://conductscience.org/library/papers/32637881 | PubMed |
| 32060787 | Mechanisms of Cannabinoids and Potential Applicability to Skin Diseases. | Clin Drug Investig | 2020 | https://conductscience.org/library/papers/32060787 | PubMed |
| 32033005 | Cannabinoids in the Pathophysiology of Skin Inflammation. | Molecules | 2020 | https://conductscience.org/library/papers/32033005 | PubMed |
| 31473845 | Recent Advances in Pharmacological Treatments of Adult Dermatomyositis. | Curr Rheumatol Rep | 2019 | https://conductscience.org/library/papers/31473845 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNA1 | 3439 | PubTator's text mining | https://conductscience.org/library/genes/3439 | NCBI Gene |
| IFNB1 | 3456 | PubTator's text mining | https://conductscience.org/library/genes/3456 | NCBI Gene |
| IL1B | 3553 | PubTator's text mining | https://conductscience.org/library/genes/3553 | NCBI Gene |
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28652111
GET https://conductscience.org/api/papers/v1/28652111/cited_by?page=2